Metabolomic Profiling of Three Species, and Their Possible Potential Role Against COVID-19
Overview
Molecular Biology
Authors
Affiliations
The COVID-19 pandemic in Egypt is a part of the worldwide global crisis of coronavirus 2 (SARS-CoV-2). The contagious life-threatening condition causes acute respiratory syndrome. The present study aimed to assess the compounds identified by LC-MS of the methanolic leaves extracts from three conifers trees cultivated in Egypt ( and ) via docking technique as potential inhibitor of COVID-19 virus on multiple targets; viral main protease (M, 6LU7), non-structural protein-16 which is a methyl transferase (nsp16, 6W4H) and RNA dependent RNA polymerase (nsp12, 7BV2). Among the three targets, nsp16 was the best target recognized by the tested compounds as can be deduced from docking studies. Moreover, the methanolic extract of showed the highest radical-scavenging activity using (DPPH test) with 53.7 µg/mL comparable to ascorbic acid with IC = 46 µg/mL The anti-inflammatory potential carried using enzyme linked immunoassay showed the highest activity for and followed by with IC = 23.20 ± 1.17 µg/mL, 82.83 ± 3.21 µg/mL and 221.13 ± 6.7 µg/mL, respectively (Celecoxib was used as a standard drug with IC = 141.92 ± 4.52 µg/mL). Moreover, a molecular docking study was carried for the LC-MS annotated metabolites to validate their anti-inflammatory inhibitory effect using Celecoxib as a reference compound and showed a high docking score (-7.7 kcal/mol) for Octadecyl () -coumarate and (-7.3 kcal/mol) for secoisolariciresinol rhamnoside.Communicated by Ramaswamy H. Sarma.
Soliman A, Sabry M, Abdelwahab G Sci Rep. 2023; 13(1):11446.
PMID: 37454176 PMC: 10349848. DOI: 10.1038/s41598-023-38143-4.
Flavonoid Components, Distribution, and Biological Activities in : A review.
Wei Q, Li Q, Wang R Molecules. 2023; 28(4).
PMID: 36838700 PMC: 9959731. DOI: 10.3390/molecules28041713.
Secondary metabolites of as potential inhibitors of SARS-CoV-2.
El-Hawary S, Ali T, Abo El-Ela S, Elwekeel A, Abdelmohsen U, Owis A RSC Adv. 2022; 12(30):19505-19511.
PMID: 35865563 PMC: 9258403. DOI: 10.1039/d2ra01306a.
Chemical constituents from and their evaluation as potential antiviral agents against SARS-CoV-2.
Hassan A, Sanad I, Allam A, Abouelela M, Sayed A, Emam S RSC Adv. 2022; 11(51):32346-32357.
PMID: 35495487 PMC: 9042241. DOI: 10.1039/d1ra05927k.
Zahran E, Sayed A, Abdelwahab M, Albohy A, Abdulrazik B, Ibrahim A RSC Adv. 2022; 11(57):36042-36059.
PMID: 35492761 PMC: 9043436. DOI: 10.1039/d1ra07103c.